The cell biology of lysosomal storage disorders

被引:604
作者
Futerman, AH [1 ]
van Meer, G
机构
[1] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel
[2] Univ Utrecht, Inst Biomembranes, Dept Membrane Enzymol, NL-3584 CH Utrecht, Netherlands
关键词
D O I
10.1038/nrm1423
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Lysosomal storage disorders, of which more than 40 are known, are caused by the defective activity of lysosomal proteins, which results in the intra-lysosomal accumulation of undegraded metabolites. Despite years of study of the genetic and molecular bases of lysosomal storage disorders, little is known about the events that lead from this intra-lysosomal accumulation to pathology. Here, we summarize the biochemistry of lysosomal storage disorders. We then discuss downstream cellular pathways that are potentially affected in these disorders and that might help us to delineate their pathological mechanisms.
引用
收藏
页码:554 / 565
页数:12
相关论文
共 114 条
  • [1] Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption
    Altmann, SW
    Davis, HR
    Zhu, LJ
    Yao, XR
    Hoos, LM
    Tetzloff, G
    Iyer, SPN
    Maguire, M
    Golovko, A
    Zeng, M
    Wang, LQ
    Murgolo, N
    Graziano, MP
    [J]. SCIENCE, 2004, 303 (5661) : 1201 - 1204
  • [2] Regulated secretion of conventional lysosomes
    Andrews, NW
    [J]. TRENDS IN CELL BIOLOGY, 2000, 10 (08) : 316 - 321
  • [3] Enzyme replacement in Anderson-Fabry disease
    Bengtsson, BÅ
    Johansson, JO
    Hollak, C
    Linthorst, G
    FeldtRasmussen, U
    [J]. LANCET, 2003, 361 (9354) : 352 - 352
  • [4] Calcium - a life and death signal
    Berridge, MJ
    Bootman, MD
    Lipp, P
    [J]. NATURE, 1998, 395 (6703) : 645 - 648
  • [5] Beutler E., 2001, METABOLIC MOL BASES, V3, P3635
  • [6] Secretory lysosomes
    Blott, EJ
    Griffiths, GM
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (02) : 122 - 131
  • [7] Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide
    Bodennec, J
    Pelled, D
    Riebeling, C
    Trajkovic, S
    Futerman, AH
    [J]. FASEB JOURNAL, 2002, 16 (13) : 1814 - +
  • [8] Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention
    Boot, RG
    Verhoek, M
    de Fost, M
    Hollak, CEM
    Maas, M
    Bleijlevens, B
    van Breemen, MJ
    van Meurs, M
    Boven, LA
    Laman, JD
    Moran, MT
    Cox, TM
    Aerts, JMFG
    [J]. BLOOD, 2004, 103 (01) : 33 - 39
  • [9] BRADY RO, 1997, GAUCHERS DIS, P621
  • [10] Functional categorization of gene expression changes in the cerebellum of a Cln3-knockout mouse model for Batten disease
    Brooks, AI
    Chattopadhyay, S
    Mitchison, HM
    Nussbaum, RL
    Pearce, DA
    [J]. MOLECULAR GENETICS AND METABOLISM, 2003, 78 (01) : 17 - 30